MedTrace Logo

Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.

NCT06989099 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-02-19

No results posted yet for this study

Summary

To learn if reconstruction of the lymphatic system at the time of axillary lymphadenectomy can reduce the risk of developing lymphedema.

Conditions

  • Lymphedema

Interventions

PROCEDURE

Immediate Lymphatic Reconstruction (ILR)/

Given by Procedure

PROCEDURE

Prophylactic Lymphovenous Bypass (pLVB)

Given by Procedure

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Mark Schaverien, MD · M.D. Anderson Cancer Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-24
Primary Completion
2028-08-01
Completion
2029-08-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06989099 on ClinicalTrials.gov